We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Denator Successfully Completes a 25.5 Million SEK Financing Round

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Denator AB has announced that the company has successfully completed a sixth round of financing, raising 25.5 million SEK (2,75 MEuro).

Major contributions came from new investors, Novo Seeds, the early stage investment group of Novo A/S, and the venture capital company, Almi Invest. Existing investors also participated in this round of financing.

In conjunction with the investment, Søren Møller, Managing Investment Director at Novo Seeds, will join the Board of Directors.

Mr. Møller explained the background to the Novo Seeds decision: “We are very pleased to co-lead this round with Almi Invest. We believe that Denator’s innovative heat-stabilization technology offer significant value to protein researchers in important areas such as neurodegenerative diseases and cancer. This is Novo Seeds’ first device investment and confirms our continued interest in funding innovative science and entrepreneurship throughout Scandinavia.”

Olof Sköld, CEO at Denator, continued: "We are extremely happy to close this 25,5 million SEK investment and wish to thank our existing investors who have continuously shown their commitment. We also welcome Novo Seeds and Almi Invest to Denator. This funding is an important milestone in our commercial development, and will enable us to strengthen our product development to meet the need our customers and continue our market expansion. We will benefit greatly from the additional resources and experience from our new investors."